Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma.

Chen, Pingping; Ma, Jiexian; Qian, Wensi; Wu, Min; Shen, Lin; Xie, Yanhui

Chen, Pingping; Ma, Jiexian; Qian, Wensi; Wu, Min; Shen, Lin; Xie, Yanhui.

Afiliación

Chen P; Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Ma J; Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Qian W; Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Wu M; Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Shen L; Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Xie Y; Department of Hematology, Huadong Hospital Affiliated to Fudan University, Shanghai, China - yanhuixie@163.com.

Minerva Pediatr (Torino) ; 76(1): 121-123, 2024 Feb.

Article en En | MEDLINE | ID: mdl-37255393

Asunto(s)

Mieloma Múltiple; Neoplasias de Células Plasmáticas; Humanos; Mieloma Múltiple/tratamiento farmacológico; Anticuerpos Monoclonales/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de Células Plasmáticas / Mieloma Múltiple Límite: Humans Idioma: En Revista: Minerva Pediatr (Torino) Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google